Zimmer Biomet Holdings (ZBH) Research & Development (2009 - 2026)

Zimmer Biomet Holdings' Research & Development history runs 18 years deep, the most recent figure standing at $103.4 million for Q1 2026.

• In Q1 2026, Research & Development fell 6.51% year-over-year to $103.4 million; the TTM figure through Mar 2026 stood at $451.3 million (up 2.54% YoY), while the FY2025 annual figure was $458.5 million, up 4.82% from the prior year.
• Research & Development was $103.4 million for Q1 2026 at Zimmer Biomet Holdings, down from $118.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $118.7 million in Q4 2025 to a low of $96.9 million in Q1 2022.
• Historically, Research & Development has averaged $109.6 million across 5 years, with a median of $110.4 million in 2023.
• Biggest YoY gain for Research & Development was 19.63% in 2022; the steepest drop was 39.76% in 2022.
• A 5-year view of Research & Development shows it stood at $108.0 million in 2022, then gained by 4.91% to $113.3 million in 2023, then slipped by 4.24% to $108.5 million in 2024, then increased by 9.4% to $118.7 million in 2025, then slipped by 12.89% to $103.4 million in 2026.
• The last three Research & Development figures came in at $103.4 million (Q1 2026), $118.7 million (Q4 2025), and $115.9 million (Q3 2025), per Business Quant data.